HMP Global produces a variety of award-winning and evidence-based continuing medical education events, journals, digital networks, and online training across a range of therapeutic areas, and backed by more than 35 years of experience in educational program and content development, marketing, meeting management, publishing, sales, and production.
Video: Addition of Venetoclax to Lenalidomide and Rituximab Therapy for Patients With Previously Untreated MCL
Kami J. Maddocks, MD, James Cancer Hospital, Ohio State University, Columbus, Ohio, discusses the results of a multicenter, open-label, nonrandomized, single-arm study.
How Digital Therapeutics Are Changing Disease Management, Diabetes Care
Daniel Sontupe moderates a conversation with Todd Prewitt, MD, and Yash Prajapati about bringing digital therapeutics for diabetes and other chronic conditions to market.
Roundtable: Skin of Color in Podiatric Dermatology
This panel dives into some of the key considerations podiatrists should know when it comes to optimizing care and outcomes for patients with skin of color presenting with lower extremity skin concerns.